- Home
- FUSB vs SXTC Comparison
FUSB vs SXTC Comparison
Compare FUSB & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUSB | SXTC |
|---|---|---|
| Founded | 1952 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.4M | 92.9M |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FUSB | SXTC |
|---|---|---|
| Price | $16.49 | $3.56 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.3K | ★ 38.7M |
| Earning Date | 04-29-2026 | 08-19-2019 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $25.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.81 | $0.03 |
| 52 Week High | $16.99 | $6.98 |
Technical Indicators
Market Signals| Indicator | FUSB | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 58.28 |
| Support Level | $15.75 | $1.67 |
| Resistance Level | $16.88 | $5.98 |
| Average True Range (ATR) | 0.22 | 0.57 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 62.32 | 64.28 |
Price Performance
Historical ComparisonAbout FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement accounts, and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.